🚀 VC round data is live in beta, check it out!
BrightSpring Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for BrightSpring Health and similar public comparables like Alibaba Health, Droga Raia, Ensign Group, MatsukiyoCocokara and more.
BrightSpring Health Overview
About BrightSpring Health
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Founded
2017
HQ
Employees
37.0K
Website
Sectors
Financials (LTM)
EV
$12B
BrightSpring Health Financials
BrightSpring Health reported last 12-month revenue of $13B and EBITDA of $666M.
In the same LTM period, BrightSpring Health generated $2B in gross profit, $666M in EBITDA, and $226M in net income.
Revenue (LTM)
BrightSpring Health P&L
In the most recent fiscal year, BrightSpring Health reported revenue of $13B and EBITDA of $618M.
BrightSpring Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $13B | XXX | $13B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 15% | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $666M | XXX | $618M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Profit | $226M | XXX | $191M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BrightSpring Health Stock Performance
BrightSpring Health has current market cap of $9B, and enterprise value of $12B.
Market Cap Evolution
BrightSpring Health's stock price is $47.27.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12B | $9B | 0.0% | XXX | XXX | XXX | $0.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrightSpring Health Valuation Multiples
BrightSpring Health trades at 0.9x EV/Revenue multiple, and 17.6x EV/EBITDA.
EV / Revenue (LTM)
BrightSpring Health Financial Valuation Multiples
As of April 19, 2026, BrightSpring Health has market cap of $9B and EV of $12B.
Equity research analysts estimate BrightSpring Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BrightSpring Health has a P/E ratio of 40.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9B | XXX | $9B | XXX | XXX | XXX |
| EV (current) | $12B | XXX | $12B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 17.6x | XXX | 19.0x | XXX | XXX | XXX |
| EV/EBIT | 24.4x | XXX | 25.9x | XXX | XXX | XXX |
| EV/Gross Profit | 5.7x | XXX | 7.7x | XXX | XXX | XXX |
| P/E | 40.4x | XXX | 47.9x | XXX | XXX | XXX |
| EV/FCF | 28.6x | XXX | 29.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BrightSpring Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BrightSpring Health Margins & Growth Rates
BrightSpring Health's revenue in the last 12 month grew by 14%.
BrightSpring Health's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.
BrightSpring Health's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BrightSpring Health's rule of X is 43% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
BrightSpring Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 22% | XXX | 26% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 43% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BrightSpring Health Public Comps
See public comps and valuation multiples for other Pharmacies and Long-Term Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BrightSpring Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Alibaba Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Ensign Group | XXX | XXX | XXX | XXX | XXX | XXX |
| MatsukiyoCocokara | XXX | XXX | XXX | XXX | XXX | XXX |
| Tsuruha Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BrightSpring Health M&A Activity
BrightSpring Health acquired XXX companies to date.
Last acquisition by BrightSpring Health was on XXXXXXXX, XXXXX. BrightSpring Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BrightSpring Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBrightSpring Health Investment Activity
BrightSpring Health invested in XXX companies to date.
BrightSpring Health made its latest investment on XXXXXXXX, XXXXX. BrightSpring Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BrightSpring Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BrightSpring Health
| When was BrightSpring Health founded? | BrightSpring Health was founded in 2017. |
| Where is BrightSpring Health headquartered? | BrightSpring Health is headquartered in United States. |
| How many employees does BrightSpring Health have? | As of today, BrightSpring Health has over 37K employees. |
| Who is the CEO of BrightSpring Health? | BrightSpring Health's CEO is Jon B. Rousseau. |
| Is BrightSpring Health publicly listed? | Yes, BrightSpring Health is a public company listed on Nasdaq. |
| What is the stock symbol of BrightSpring Health? | BrightSpring Health trades under BTSG ticker. |
| When did BrightSpring Health go public? | BrightSpring Health went public in 2024. |
| Who are competitors of BrightSpring Health? | BrightSpring Health main competitors are Alibaba Health, Droga Raia, Ensign Group, MatsukiyoCocokara. |
| What is the current market cap of BrightSpring Health? | BrightSpring Health's current market cap is $9B. |
| What is the current revenue of BrightSpring Health? | BrightSpring Health's last 12 months revenue is $13B. |
| What is the current revenue growth of BrightSpring Health? | BrightSpring Health revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of BrightSpring Health? | Current revenue multiple of BrightSpring Health is 0.9x. |
| Is BrightSpring Health profitable? | Yes, BrightSpring Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BrightSpring Health? | BrightSpring Health's last 12 months EBITDA is $666M. |
| What is BrightSpring Health's EBITDA margin? | BrightSpring Health's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of BrightSpring Health? | Current EBITDA multiple of BrightSpring Health is 17.6x. |
| What is the current FCF of BrightSpring Health? | BrightSpring Health's last 12 months FCF is $411M. |
| What is BrightSpring Health's FCF margin? | BrightSpring Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of BrightSpring Health? | Current FCF multiple of BrightSpring Health is 28.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.